BioVie (BIVI)
NASDAQ:BIVI
US Market

BioVie (BIVI) Financial Statements

261 Followers

BioVie Financial Overview

BioVie's market cap is currently ―. The company's EPS TTM is $-0.961; its P/E ratio is -0.46; BioVie is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 8.33M$ -7.58M$ -9.71M-$ 14.16M
EBITDA$ 8.41M$ -7.52M$ -9.61M-$ 14.10M
Net Income Common Stockholders$ -8.95M$ -8.40M$ -10.71M-$ 15.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 30.35M$ 20.23M$ 21.21M$ 19.46M$ 31.28M
Total Assets$ 31.77M$ 21.49M$ 23.76M$ 35.10M$ 45.18M
Total Debt$ 8.42M$ 10.26M$ 12.39M$ 14.42M$ 13.89M
Net Debt$ -21.93M$ -9.97M$ -8.83M$ -5.04M$ -17.38M
Total Liabilities$ 12.85M$ 14.00M$ 16.21M$ 19.76M$ 23.46M
Stockholders Equity$ 18.93M$ 7.49M$ 7.55M$ 15.34M$ 21.72M
Cash Flow-
Free Cash Flow$ -5.85M$ -5.91M$ -12.18M$ -11.32M-
Operating Cash Flow$ -5.85M$ -5.91M$ -12.18M$ -11.32M-
Investing Cash Flow--$ 14.53M$ -1.80M-
Financing Cash Flow$ 15.98M$ 4.92M$ -594.16K$ 1.27M-
Currency in USD

BioVie Earnings and Revenue History

BioVie Debt to Assets

BioVie Cash Flow

BioVie Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis